Sorafenib

signal transducer and activator of transcription 3 ; Mus musculus







16 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 35600776 Ginsenoside Rg3 in combination with artesunate overcomes sorafenib resistance in hepatoma cell and mouse models. 2022 May 2
2 33176070 Sorafenib and CuB exert synergistic antitumor effects against hepatocellular carcinoma cells via inhibition of STAT3 phosphorylation. 2021 Jan 2
3 33410581 Inflammatory microenvironment of fibrotic liver promotes hepatocellular carcinoma growth, metastasis and sorafenib resistance through STAT3 activation. 2021 Feb 5
4 34122447 Sorafenib Modulates the LPS- and Aβ-Induced Neuroinflammatory Response in Cells, Wild-Type Mice, and 5xFAD Mice. 2021 1
5 28282575 Sorafenib combined with HER-2 targeted vaccination can promote effective T cell immunity in vivo. 2017 May 1
6 26544779 Convection-enhanced delivery of sorafenib and suppression of tumor progression in a murine model of brain melanoma through the inhibition of signal transducer and activator of transcription 3. 2016 May 7
7 26679051 A combination of sorafenib and SC-43 is a synergistic SHP-1 agonist duo to advance hepatocellular carcinoma therapy. 2016 Feb 28 1
8 25953027 Evaluation of in vivo responses of sorafenib therapy in a preclinical mouse model of PTEN-deficient of prostate cancer. 2015 May 8 1
9 24735751 A sorafenib derivative and novel SHP-1 agonist, SC-59, acts synergistically with radiotherapy in hepatocellular carcinoma cells through inhibition of STAT3. 2014 Jul 28 1
10 25333973 Serial low doses of sorafenib enhance therapeutic efficacy of adoptive T cell therapy in a murine model by improving tumor microenvironment. 2014 1
11 25436606 Distinct behaviour of sorafenib in experimental cachexia-inducing tumours: the role of STAT3. 2014 1
12 23948302 STAT3-mediated attenuation of CCl4-induced mouse liver fibrosis by the protein kinase inhibitor sorafenib. 2013 Oct 6
13 22922424 Sorafenib down-regulates expression of HTATIP2 to promote invasiveness and metastasis of orthotopic hepatocellular carcinoma tumors in mice. 2012 Dec 1
14 21354226 Signal transducer and activator of transcription 3 is a major kinase-independent target of sorafenib in hepatocellular carcinoma. 2011 Nov 6
15 21360571 Sorafenib inhibits transforming growth factor β1-mediated epithelial-mesenchymal transition and apoptosis in mouse hepatocytes. 2011 May 1
16 20884624 Sorafenib overcomes TRAIL resistance of hepatocellular carcinoma cells through the inhibition of STAT3. 2010 Nov 1 6